Clinical Trial Update: A Study of the Safety and Effectiveness of JUVÉDERM VOLUMA® XC Injectable Gel for Cheek Augmentation Using Cannula [NA]

View source ↗

Summary

A completed clinical trial evaluating the safety and effectiveness of JUVÉDERM VOLUMA XC for cheek augmentation using a cannula.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Volume Deficit in the Mid-face

Drugs mentioned

• JUVÉDERM VOLUMA XC injectable gel (hyaluronic acid filler)

Snippet

Sponsor: Allergan | Conditions: Age-related Volume Deficit in the Mid-face | NA | Status: COMPLETED | Results posted: 2019-08-05